Microbiological Profile of Patients with Aspiration Pneumonia Identified by Combined Detection Methods
Hui Xu,Ruixue Zhang,Xiaoxue Zhang,Yueguang Cheng,Liping Lv,Lianjun Lin
DOI: https://doi.org/10.2147/idr.s461935
2024-05-25
Infection and Drug Resistance
Abstract:Hui Xu, 1 Ruixue Zhang, 1 Xiaoxue Zhang, 1 Yueguang Cheng, 2 Liping Lv, 3 Lianjun Lin 1 1 Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China; 2 Department of Emergency, Beijing Jingmei Group General Hospital, Beijing, People's Republic of China; 3 Department of Interventional Pulmonology, Anhui Chest Hospital, Hefei, People's Republic of China Correspondence: Lianjun Lin, Department of Geriatrics, Peking University First Hospital, Xishiku Avenue 8, Xicheng District, Beijing, 100034, People's Republic of China, Tel +8613671246076, Fax +86-10-83572981, Email Purpose: Aspiration pneumonia (AP) challenges public health globally. The primary aim of this study was to ascertain the microbiological profile characteristics of patients with AP evaluated by combined detection methods, including conventional microbiological tests (CMTs), chips for complicated infection detection (CCID), and metagenomic next-generation sequencing (mNGS). Patients and Methods: From June 2021 to March 2022, a total of thirty-nine patients with AP or community-acquired pneumonia with aspiration risk factors (AspRF-CAP) from 3 hospitals were included. Respiratory specimens, including bronchoalveolar lavage fluid (BALF), sputum, and tracheal aspirate, were collected for microorganism detection. Results: Patients with AP were more inclined to be older, to have a shorter duration from illness onset to admission, to have a higher prevalence of different underlying diseases, particularly diabetes mellitus, chronic heart disease, and cerebrovascular disease, and to have a higher CURB-65 score (all P < 0.05). A total of 213 and 31 strains of microorganisms were detected in patients with AP and AspRF-CAP, respectively. The most common pathogens in AP were Corynebacterium striatum (17/213, 7.98%), Pseudomonas aeruginosa (15/213, 7.04%), Klebsiella pneumoniae (15/213, 7.04%), and Candida albicans (14/213, 6.57%). Besides, the most common pathogens in AspRF-CAP were Candida albicans (5/31, 16.13%), Pseudomonas aeruginosa (3/31, 9.68%) and Klebsiella pneumoniae (3/31, 9.68%). Moreover, Klebsiella pneumoniae (7/67, 10.45%) and Candida glabrata (5/67, 7.46%) were the most common pathogens among the 9 non-survived patients with AP. Conclusion: The prevalent pathogens detected in cases of AP were Corynebacterium striatum, Pseudomonas aeruginosa, Klebsiella pneumoniae , and Candida albicans . Early combined detection methods for patients with AP enhance the positive detection rate of pathogens and potentially expedites the initiation of appropriate antibiotic therapeutic strategies. Keywords: aspiration, pneumonia, microbiology, metagenomic next-generation sequencing, chips, combined detection Aspiration is defined as the inhalation of oropharyngeal or gastric contents into the larynx and lower respiratory tract. 1 Aspiration pneumonia (AP) refers to the process of alveolar and systemic inflammation caused by the inhalation of oropharyngeal or gastrointestinal secretions colonized by pathogenic bacteria into the lower respiratory tract. 2 Multiple risk factors, such as impaired swallowing, impaired cough reflex, impaired consciousness, degenerative neurologic diseases, dementia, stroke, and enteral tube feeding, are associated with AP. 1,3 Our previous study has reported that the incidence rates of hospitalized AP and pneumonia patients with aspiration risk factors (AspRF) were 9.4 and 102.9 per 100,000 person-years, respectively. 4 The incidences of AP increased rapidly with age. 4 It has been reported that patients with AP have higher morbidity and mortality than those with non-aspiration community-acquired pneumonia (CAP). 5 Significant healthcare and economic burdens are foreseeable as the population ages and the prevalence of AP increases. However, prophylactic use of antibiotics in AP does not provide clinical benefit and may drive resistance, resulting in the need for escalation of antibiotic therapy for patients with AP. 6 Additionally, inadequate empirical antimicrobial therapy may contribute to significant increase of mortality. 7 Therefore, early identification and characterization of AP pathogens is critical for administering appropriate antimicrobial treatment and improving clinical outcomes. Accumulating evidence revealed a fading importance of anaerobic bacteria in AP, with Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae , and Pseudomonas aeruginosa , becoming common causative organisms. 5,8 Beside -Abstract Truncated-
pharmacology & pharmacy,infectious diseases